AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, and YouTube.

We are AbbVie. A global Fortune 500 biopharmaceutical company creating life-changing medicines and first-in-kind solutions that make a real difference in people’s lives.

Our 50,000+ employees across geographies, disciplines, and therapeutic areas put impact at the core of every decision. With over $50B invested in R&D since our founding in 2013, we’re always focused on helping people and communities thrive for generations to come.

1 North Waukegan Road
North Chicago, IL 60064

Tel: 1-800-255-5162

Visit website

Email Us

Stock Symbol: ABBV
Stock Exchange: NYSE

NEWS

SKYRIZI is the new option for psoriatic arthritis.

Business

AbbVie Pulls Plug on Parkinson’s Partnership With BioArctic

AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson’s Disease and other movement disorders.

April 20, 2022

2 min read

Vanessa Doctor, MS

BioMidwest

Eli Lilly Faces $165M in Charges over R&D Acquisitions in Latest SEC Exchange

The charges come from several in-process research and development projects acquired outside of a business combination.

April 18, 2022

2 min read

Hannah Chudleigh

Drug Development

Clinical Catch-Up: AACR, AAN and COVID-19

It was a very busy week for clinical trial news, with much of it coming out of the American Association of Cancer Research Annual Meeting. Read on for details.

April 15, 2022

12 min read

Mark Terry

Business

Sanofi, AbbVie and Genmab Celebrate Mid-Phase Trial Wins

AbbVie and Genmab announced positive topline results from their Phase I/II trial for lymphoma treatment; Sanofi posted positive results from its Phase I/II trial for the treatment of ITP.

April 14, 2022

2 min read

Vanessa Doctor, MS

Drug Development

AACR Spotlight: Victoria’s Secret Awards 5 Female Cancer Researchers, AbbVie and More

As the American Association of Cancer Research (AACR) Annual Meeting wraps up, there were some surprising and exciting research news and presentations.

April 13, 2022

4 min read

Mark Terry

Job Trends

AbbVie, Others Spring Into New Real Estate, Personnel Investments

With Spring comes new beginnings, and companies within the biopharmaceutical industry are blossoming with fresh ventures. Here are some of them:

April 13, 2022

2 min read

Jazmine Colatriano

Policy

US Congress Introduces Bills to Strengthen Pharma Competition, Promote Innovation

The new bills result from a three-year investigation that honed in on anti-competitive efforts that have prevented generic drugs and biosimilars from entering the market.

April 8, 2022

3 min read

Alex Keown

Business

BioSpace Looks at the Top 8 Biopharma Companies by Net Income

Here’s a look at the eight most profitable biopharma companies around the world. Profitability, in this case, refers to net income, as opposed to total revenue or sales.

April 6, 2022

3 min read

Mark Terry